Video

Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC

Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma

Image-defined risk factors predict surgical outcomes in paediatric neuroblastic tumours

Functional dependence predicts poorer survival in adults aged 80 and over with NSCLC

Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC

TELENEC reduces referral delays for childhood cancer care in Paraguay

Drone delivery could improve access to childhood cancer medicines in Ghana

Transcriptome-Wide Association Study identifies genetic factors linked to subsequent cancers in childhood cancer survivors

Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC

Cemiplimab shows strong survival benefit in KRAS G12C positive advanced NSCLC

Challenges in doing clinical research in the LATAM region

Amivantamab plus chemotherapy extends overall survival in EGFR exon 20 insertion NSCLC